Nov 08, 2019 · ADVM INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Adverum Biotechnologies, Inc. and Encourages Investors to Contact the Firm Feb 26 SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Adverum Biotechnologies, Inc. and Encourages Investors with Losses to Contact the Firm ADVM Adverum Biotechnologies Inc. stock Adverum Biotechnologies Inc. (NASDAQ: ADVM) closed at 10.99 per share at the end of the most recent trading day (a -3.85 % change compared to the prior day closing price) with a volume of 634.18K shares and market capitalization of 778.48M.Is a component of indexes and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 96 people. Intelsat S.A. Common Shares (I) News Headlines | Nasdaq
ADVM News: Earnings, Analyst Moves, and More
$ADVM ADVM-022 gene therapy for anti-VEGF had clinical issues but still climbing ACRX, added to Nasdaq Biotech Index ($IBB) effective 12/24 TRVN , rose +30% prior to PDUFA date, many people speculating an approval on StockTwits 2019年7月15日 Adverum Biotechnologies Inc（NASDAQ: ADVM）股价2019年迄今已经暴涨超过 390%。 该股股价年内多数时间均维持稳步上升趋势，但真正爆发是 Natural Gas, 1.7510, +0.0200, +1.16%. Gold, 1705.40, +11.50, +0.68%. Dow, 22401.00, -87.00, -0.39%. S&P 500, 2637.25, -7.25, -0.27%. Nasdaq 100, 8008.00 1 Out 2019 Sina Weibo SiteJot Skype Slashdot SMS StockTwits Svejo Symbaloo Bookmarks Threema Trello Tuenti Twiddla TypePad Post Viadeo Viber ADVM Adverum Biotechnologies, Inc — Stock ... - StockTwits Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures.
Nov 08, 2019 · Adverum Biotechnologies, Inc., a gene therapy company, engages in discovering and developing novel medicines that offer therapeutic benefit to …
Find the latest news headlines from Intelsat S.A. Common Shares (I) at Nasdaq.com.
ADVM stock: Adverum Biotechnologies Inc
Stock analysis for Adverum Biotechnologies Inc (ADVM:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. NASDAQ:ADVM Adverum Biotechnologies Stock Price, Forecast ... Adverum Biotechnologies Inc (NASDAQ:ADVM) released its earnings results on Thursday, March, 12th. The biotechnology company reported ($0.29) earnings per share for the quarter, hitting the Thomson Reuters' consensus estimate of ($0.29). View Adverum Biotechnologies' earnings history. $ADVM Stock Technical Analysis | Adverum | SwingTradeBot.com Nov 08, 2019 · Adverum Biotechnologies, Inc., a gene therapy company, engages in discovering and developing novel medicines that offer therapeutic benefit to … ADVM -- Is Its Stock Price A Worthy Investment? Learn More.
NASDAQ0.95%. Trending now. IFRX61.00% +Initiations 3/17: $ADVM $ADXL $NLTX $OOMA $SI $THR -Initiations 3/17: 1. Stockhoot3/16/20, 03:08 AM.
ADVM | Adverum Biotechnologies Inc. Options | MarketWatch Nov 05, 2019 · Adverum Biotechnologies Inc. historial options data by MarketWatch. View ADVM option chain data and pricing information for given maturity periods.
The Technical Chart allows you to overlay 30 types of technical indicators on price charts for more than 20,000 equities and indices. All indicators are customizable providing you the ability look at charts exactly the way you like. Once your chart is drawn, save your custom chart view for easy access or apply to another security. Adverum Biotechnologies Inc ADVM - Quotes, Financials ... Adverum Biotechnologies, Inc. is a clinical-stage biotechnology company that engages in the development of novel gene therapies to treat patients with sight-threatening ophthalmic diseases.